DR. NIKHIL PALEKAR – NEW ALZHEIMER’S DRUG “LAQEMBI” - 8 19 23DR. NIKHIL PALEKAR – NEW ALZHEIMER’S DRUG “LAQEMBI” - 8 19 23
American Medicine Today - Radio
THE FDA RECENTLY GAVE FULL APPROVAL TO A NEW DRUG CALLED LEQEMBI, WHICH IS BEING HAILED AS “A NEW ERA IN ALZHEIMER’S TREATMENT”. WE SPEAK WITH NIKHIL PALEKAR, MD - DIRECTOR OF THE STONY BROOK CENTER OF EXCELLENCE FOR ALZHEIMER’S DISEASE AND DIRECTOR...
10:07•19 Aug 2023
Leqembi: A New Hope in Alzheimer's Treatment
Episode Overview
- Leqembi: A groundbreaking drug slowing cognitive decline by 30%
- Dr. Alfred Benatti shares intriguing experiences with cervical spine decompression and its effects on cognitive abilities
- Dr. Palakar emphasizes the importance of early detection and treatment for Alzheimer's
- Discussion on the potential vascular component of Alzheimer's
- Valuable resources shared for those seeking further information and assistance
“This medication and a group of these medications called monoclonal antibodies, they actually go and bind to these amyloid plaques and clear them out of the brain. So obviously this isn't a cure per se, but it's definitely groundbreaking.”
Ever wondered if there's a breakthrough on the horizon for Alzheimer's treatment? In this episode of 'American Medicine Today', hosts Kimberly Benatti and Ethan Uecker sit down with Dr. Nikhil Palekar, Director of the Stony Brook Center of Excellence for Alzheimer's Disease, to discuss the FDA-approved drug Leqembi. This new medication is being celebrated as a significant advancement in the fight against Alzheimer's. Dr.
Palekar explains how Leqembi works by targeting and removing amyloid plaques from the brain, potentially slowing cognitive decline by up to 30%. While it's not a cure, it offers hope for those with mild symptoms. Adding another layer to the conversation, Dr. Alfred Benatti shares intriguing cases where cervical spine decompression has positively affected cognitive abilities in patients showing early signs of Alzheimer's.
This opens up a fascinating discussion about the possible vascular aspects of the disease and underscores the importance of early detection and intervention. Dr. Palekar wraps up the episode by providing valuable resources for those seeking more information and support, leaving listeners with a renewed sense of hope and encouragement. If you're looking to stay informed about cutting-edge treatments and innovative approaches to Alzheimer's, this episode is a must-listen.
Do you want to link to this podcast?
Get the buttons here!
More From This Show
The latest episodes from the same podcast.
Related Episodes
Similar episodes from other shows in the catalogue.